Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Appointed director CC transcript Inv. presentation Accel. buyback
|
OMNICARE INC (OCR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/11/2016 |
SC 13G/A
| Boston Partners reports a 0% stake in Omnicare Inc |
02/10/2016 |
SC 13G/A
| Oakmark Funds reports a 0% stake in Omnicare |
01/26/2016 |
SC 13G/A
| Iridian Asset Management has filed a Schedule 13D for Omnicare, Inc.. |
10/14/2015 |
8-K
| Quarterly results |
08/18/2015 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs:
|
"Amended and Restated Certificate of Incorporation of Omnicare, Inc",
"Amended and Restated By-laws of Omnicare, Inc",
"First Supplemental Indenture to the Second Supplemental Indenture, between Omnicare and the predecessor to the Trustee, to that certain base indenture, (the “Base Indenture”), with respect to the 4.00% Junior Subordinated Convertible Debentures due 2033",
"First Supplemental Indenture to the Third Supplemental Indenture, between Omnicare and the predecessor to the Trustee, to the Base Indenture, with respect to the Series B 4.00% Junior Subordinated Convertible Debentures due 2033",
"First Supplemental Indenture to the Seventh Supplemental Indenture, among Omnicare, the guarantors named therein and the Trustee, to the Base Indenture, with respect to the 3.75% Convertible Senior Subordinated Notes due 2025",
"First Supplemental Indenture to the Ninth Supplemental Indenture, among Omnicare, the guarantors named therein and the Trustee, to the Base Indenture, with respect to the 3.5% Convertible Senior Subordinated Notes due 2044",
"First Supplemental Indenture to the Indenture, among Omnicare, Omnicare Purchasing Company L.P., as guarantor, and the predecessor to the Trustee, with respect to the 3.25% Convertible Senior Debentures due 2035",
"First Supplemental Indenture to the Indenture, among Omnicare, Omnicare Purchasing Company L.P., as guarantor, and the Trustee, with respect to the 3.25% Convertible Senior Exchange Debentures due 2035" |
|
08/06/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
08/06/2015 |
8-K
| Other Events |
08/05/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
07/31/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
07/29/2015 |
8-K
| Other Events, Financial Statements and Exhibits
Docs:
|
"Notice to holders of Omnicare, Inc.'s 3.75% Convertible Senior Subordinated Notes due 2025",
"Notice to holders of Omnicare, Inc.'s 3.50% Convertible Senior Subordinated Notes due 2044",
"Notice to holders of Omnicare, Inc.'s 3.25% Convertible Senior Debentures due 2035",
"Notice to holders of Omnicare, Inc.'s 3.25% Convertible Senior Exchange Debentures due 2035",
"Notice to holders of Omnicare, Inc.'s 4.00% Junior Subordinated Convertible Debentures due 2033 and Omnicare Capital Trust I's Trust Preferred Equity Income Redeemable Securities",
"Notice to holders of Omnicare, Inc.'s Series B 4.00% Junior Subordinated Convertible Debentures due 2033 and Omnicare Capital Trust II's Trust Preferred Equity Income Redeemable Securities" |
|
07/29/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
07/24/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
07/24/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
07/20/2015 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
07/06/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
06/05/2015 |
8-K
| Submission of Matters to a Vote of Security Holders |
05/26/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/22/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
05/22/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/22/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/21/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/21/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/21/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
05/21/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/12/2015 |
8-K
| Investor presentation |
04/29/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
04/29/2015 |
8-K
| Quarterly results |
04/17/2015 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
02/25/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
02/25/2015 |
8-K
| Quarterly results |
02/12/2015 |
SC 13G/A
| Boston Partners reports a 7.8% stake in Omnicare Inc |
02/11/2015 |
SC 13G/A
| Oakmark Funds reports a 5.4% stake in Omnicare |
02/11/2015 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.1% stake in Omnicare Inc |
02/06/2015 |
SC 13G/A
| BlackRock Inc. reports a 7.3% stake in OMNICARE INC |
|
|
|